Risk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study
Authors:
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 39 (4) , 300-309
Abstract
No abstract availableKeywords
Funding Information
- Actelion Pharmaceuticals
This publication has 16 references indexed in Scilit:
- Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertensionEuropean Respiratory Journal, 2017
- Assessing risk in pulmonary arterial hypertension: what we know, what we don'tEuropean Respiratory Journal, 2017
- A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertensionEuropean Heart Journal, 2017
- Selexipag for the Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2015
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Respiratory Journal, 2015
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Heart Journal, 2015
- Validation of two predictive models for survival in pulmonary arterial hypertensionEuropean Respiratory Journal, 2015
- The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial HypertensionChest, 2012
- Predicting Survival in Pulmonary Arterial HypertensionCirculation, 2010
- The Challenge of Subgroup Analyses — Reporting without DistortingNew England Journal of Medicine, 2006